University of Texas Southwestern Medical Center: Carcinoma, Non-Small-Cell Lung trials

The registry lists 18 Carcinoma, Non-Small-Cell Lung studies with University of Texas Southwestern Medical Center as lead sponsor. 2 are open to participants now and 9 have results posted.

Early Phase 1 2Phase 1 5Phase 2 8Phase 3 2No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central LungRecruitingNCT06712745Early Phase 1
• JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung CancerRecruitingNCT02468024Phase 3
• Durvalumab and Stereotactic Radiotherapy for Advanced NSCLCTerminatedNCT04786093Phase 2Results posted
• Phase II Concurrent Durvalumab and Radiotherapy for for Stage III Non-Small Cell Lung CancerCompletedNCT04003246Phase 2Results posted
• Phase I Study of Accelerated Hypofractionated Image-Guided Radiation TherapyCompletedNCT03623334Not applicableResults posted
• Phase 1/2 Trial of Selinexor (KPT-330) With Docetaxel for Non-small Cell Lung Cancer (NSCLC)TerminatedNCT03095612Phase 1/2Results posted
• Neoadjuvant Itraconazole in Non-small Cell Lung CancerCompletedNCT02357836Early Phase 1Results posted
• Maintenance Chemotherapy Versus Consolidative Stereotactic Body Radiation Therapy (SBRT) Plus Maintenance Chemotherapy for Stage IV Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II TrialCompletedNCT02045446Phase 2Results posted
• Hypofractionated Image-Guided Radiation Therapy (IGRT) in Patients With Stage II-III Non-Small Cell Lung CancerCompletedNCT01459497Phase 3Results posted
• Romidepsin and Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT01302808Phase 1Results posted
• Erlotinib and SBRT in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerCompletedNCT00547105Phase 2Results posted
• Pre-operative Tumor Treating Fields in Patients With Resectable Lung CancerWithdrawnNCT06552000Not applicable
• Durvalumab (MEDI4736) and Radiosurgery (fSRT Vs. PULSAR) for the Treatment of Non-Small Cell Lung Cancer Brain MetastasesWithdrawnNCT04889066Phase 2
• Study of Osimertinib and Stereotactic Ablative Radiation (SABR) in EGFR Mutant NSCLCActive, not recruitingNCT03667820Phase 2
• Trial of Dose Escalated BGB324 in Previously Treated Non-small Cell Lung Cancer.CompletedNCT02922777Phase 1
• Patient Navigation for Lung Cancer Screening in an Urban Safety-Net SystemCompletedNCT02758054Not applicable
• Specialized Radiation Therapy in Treating Patients With Stage II, Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer and Poor Performance StatusCompletedNCT00986297Phase 1
• Sorafenib and High-Dose Carboplatin, Paclitaxel, and External-Beam Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung CancerWithdrawnNCT00547443Phase 1/2